DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
This Quarter Return
+24.11%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$2.85B
AUM Growth
+$276M
(+11%)
Cap. Flow
-$74.2M
Cap. Flow
% of AUM
-2.6%
Top 10 Holdings %
Top 10 Hldgs %
41.33%
Holding
76
New
13
Increased
15
Reduced
16
Closed
18
Top Buys
| 1 |
argenx
ARGX
|
$114M |
| 2 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$52.8M |
| 3 |
Sarepta Therapeutics
SRPT
|
$48.2M |
| 4 |
Tourmaline Bio
TRML
|
$47.5M |
| 5 |
ABVX
Abivax
ABVX
|
$46M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$134M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$80.2M |
| 3 |
Immunovant
IMVT
|
$75.7M |
| 4 |
Structure Therapeutics
GPCR
|
$65.8M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$43M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALLK
51
DELISTED
Allakos
ALLK
| $6.85M | 0.23% |
+2,510,736
| New | +$6.85M |
|
|
SYRS
52
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $6.45M | 0.22% |
828,485
| – | – |
|
53
Protagonist Therapeutics
PTGX
$3.66B
| $6.31M | 0.21% |
+275,201
| New | +$6.31M |
|
|
54
Jazz Pharmaceuticals
JAZZ
$7.95B
| $5.94M | 0.2% |
48,280
-1,089,765
| -96% | -$134M |
|
|
VIGL
55
DELISTED
Vigil Neuroscience
VIGL
| $5.39M | 0.18% |
1,594,931
-172,200
| -10% | -$582K |
|
56
Aligos Therapeutics
ALGS
$73M
| $4.05M | 0.14% |
+244,111
| New | +$4.05M |
|
57
GH Research
GHRS
$868M
| $2.9M | 0.1% |
499,400
| – | – |
|
58
Acumen Pharmaceuticals
ABOS
$84.8M
| – | – |
-2,513,044
| Closed | -$10.4M |
|
59
Amylyx Pharmaceuticals
AMLX
$876M
| – | – |
-1,259,335
| Closed | -$23.1M |
|
60
Astria Therapeutics
ATXS
$389M
| – | – |
-1,037,873
| Closed | -$7.74M |
|
61
Beam Therapeutics
BEAM
$1.88B
| – | – |
-1,015,641
| Closed | -$24.4M |
|
62
BioNTech
BNTX
$24.1B
| – | – |
-200,000
| Closed | -$21.7M |
|
|
CMPS
63
Compass Pathways
CMPS
$451M
| – | – |
-328,424
| Closed | -$2.43M |
|
64
89bio
ETNB
$1.39B
| – | – |
-91,078
| Closed | -$1.41M |
|
65
Heron Therapeutics
HRTX
$204M
| – | – |
-2,086,704
| Closed | -$2.15M |
|
66
Century Therapeutics
IPSC
$41.5M
| – | – |
-543,008
| Closed | -$1.09M |
|
67
Moderna
MRNA
$9.22B
| – | – |
-200,000
| Closed | -$20.7M |
|
68
Neurocrine Biosciences
NBIX
$13.5B
| – | – |
-300,000
| Closed | -$33.8M |
|
69
Nuvation Bio
NUVB
$1.09B
| – | – |
-7,720,688
| Closed | -$10.3M |
|
70
Novavax
NVAX
$1.2B
| – | – |
-1,000,000
| Closed | -$7.24M |
|
71
NovoCure
NVCR
$1.36B
| – | – |
-2,500,000
| Closed | -$40.4M |
|
72
Prothena Corp
PRTA
$449M
| – | – |
0
| – | – |
|
|
SLRN
73
DELISTED
ACELYRIN
SLRN
| – | – |
-551,289
| Closed | -$5.61M |
|
74
10x Genomics
TXG
$1.65B
| – | – |
-182,691
| Closed | -$7.54M |
|
|
MORF
75
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| – | – |
-470,647
| Closed | -$10.8M |
|